Research programme: MRI contrast agents and imaging - PhotoBiotics

Drug Profile

Research programme: MRI contrast agents and imaging - PhotoBiotics

Latest Information Update: 28 Jul 2016

Price : $50

At a glance

  • Originator PhotoBiotics
  • Class Antibody diagnostics; Diagnostic conjugates; Drug conjugates; Immunoconjugates
  • Mechanism of Action Magnetic resonance imaging enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Preclinical Cancer

Most Recent Events

  • 28 Jul 2016 Research programme: MRI contrast agents and imaging - PhotoBiotics is available for licensing - http://www.photobiotics.com/partner-opportunities.shtml
  • 28 Jul 2016 Preclinical trials in Cancer (Diagnosis) in United Kingdom (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top